Company intelligence / Profile preview

VerImmune

District of Columbia, United Statesverimmune.com ↗

Ownership: Private
Development stage: Preclinical

Overview

VerImmune has developed a proprietary ViP™ platform that redirects the body’s pre-existing immune memory—acquired from past infections or childhood vaccinations—toward cancer cells. Their lead candidate, VERI‑101, leverages this approach by targeting tumor-associated heparan sulfate chains and harnessing CMV-specific immunity. The company has completed successful FDA pre‑IND meetings and aims to file an IND soon. No human clinical results have been reported yet; all data are preclinical.[2][4][5]

Therapeutic areas: Oncology
Modalities: Virus-inspired Particle (ViP™) platform (biologic/particle-based immunotherapy)Immune redirection therapy
Industry: Biotech

Drug pipeline

1 asset

VERI-101

Preclinical

Partnerships

Janssen Research & Development LLC / Johnson & Johnson Innovation – research collaboration on AIR-ViP technology[3]Fosun Pharma USA – milestone payment partnership related to process development of VERI‑101[4]

Beyond the preview

Go deeper on VerImmune.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VerImmune.

Explore the full profile